Olabisi Onabanjo University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2013
NCT01911494
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Olabisi Onabanjo University Teaching Hospital